உலகளாவிய தடுப்பூசி தகவல்கள் வலைப்பின்னல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

F.D.A. Attaches Warning of Rare Nerve Syndrome to Johnson & Johnson Covid Vaccine Sharon LaFraniere and Noah Weiland © James Estrin/The New York Times Administering the Johnson & Johnson vaccine in Brooklyn in May. About 12.8 million people or about 8 percent of the fully vaccinated population in the United States have received the Johnson & Johnson shot. The Food and Drug Administration warned on Monday that Johnson & Johnson’s coronavirus vaccine can lead to an increased risk of a rare neurological condition known as Guillain–Barré syndrome, another setback for a vaccine that has largely been sidelined in the United States. Although regulators have found that the chances of developing the condition are low, they appear to be three to five times higher among recipients of the Johnson & Johnson vaccine than among the general population in the United States, according to people familiar with the decision. The warning was attached to factsheets about

New yorkUnited statesAlex gorskySteven blackJames estrinCenters for diseaseGlobal vaccine data networkDrug administrationAfrican unionCincinnati children hospital medical centerNew york times administeringCincinnati childrenHospital medical centerVaccine adverse event reporting systemDisease controlEmergent biosolutions